A Phase 1/2 Uncontrolled, Open Label Study Of Photodynamic Vaccination [verteporfin and detox-B adjuvant] In Patients With Stage III/IV Malignant Melanoma
Phase of Trial: Phase I/II
Latest Information Update: 06 Feb 2009
At a glance
- Drugs Detox B; Verteporfin
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 18 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Sep 2005 New trial record.